⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for apl

Every month we try and update this database with for apl cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
AIDA 2000 GuidelinesNCT01064570
Acute Promyeloc...
all-trans retin...
1 Year - 60 YearsGruppo Italiano Malattie EMatologiche dell'Adulto
AIDA 2000 GuidelinesNCT01064570
Acute Promyeloc...
all-trans retin...
1 Year - 60 YearsGruppo Italiano Malattie EMatologiche dell'Adulto
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersNCT00421213
Hematologic Neo...
Bone Marrow Neo...
Non-Hodgkin's L...
Darinaparsin
18 Years - Alaunos Therapeutics
A Safety Study of SGN-CD33A in AML PatientsNCT01902329
Acute Myelogeno...
Acute Myeloid L...
Acute Promyeloc...
HMA
SGN-CD33A
18 Years - Seagen Inc.
All-trans Retinoic Acid, and Arsenic +/- IdarubicinNCT00413166
Acute Promyeloc...
All-Trans Retin...
Arsenic Trioxid...
Idarubicin
Gemtuzumab Ozog...
- M.D. Anderson Cancer Center
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic LeukemiaNCT00675870
Acute Promyeloc...
NRX 195183 Soft...
18 Years - NuRx Pharmaceuticals, Inc.
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersNCT00421213
Hematologic Neo...
Bone Marrow Neo...
Non-Hodgkin's L...
Darinaparsin
18 Years - Alaunos Therapeutics
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)NCT00591526
Leukemia, Promy...
Arac
- Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
A Safety Study of SGN-CD33A in AML PatientsNCT01902329
Acute Myelogeno...
Acute Myeloid L...
Acute Promyeloc...
HMA
SGN-CD33A
18 Years - Seagen Inc.
Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic LeukemiaNCT00675870
Acute Promyeloc...
NRX 195183 Soft...
18 Years - NuRx Pharmaceuticals, Inc.
Safety, Efficacy, & Pharmacokinetic Study of Tamibarotene to Treat Patients With Relapsed or Refractory APLNCT00520208
Acute Promyeloc...
Tamibarotene
18 Years - CytRx
APL93: Timing of CxT and Role of MaintenanceNCT00599937
Leukemia, Promy...
ATRA
ATRA and or Che...
- Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic LeukemiaNCT05881265
APL
Chidamide+venet...
16 Years - 70 YearsShanghai Jiao Tong University School of Medicine
A Randomized Trial Assessing the Roles of AraC in Newly Diagnosed APL Promyelocytic Leukemia (APL)NCT00591526
Leukemia, Promy...
Arac
- Groupe d'etude et de travail sur les leucemies aigues promyelocytaires
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: